April is Parkinson’s Awareness Month and the California Institute for Regenerative Medicine (CIRM) is joining the campaign to #Take6ForPD—take 6 minutes to raise Parkinson’s awareness and highlight our commitment to funding research for the disease. What is Parkinson’s Disease? Parkinson's disease (PD) is a neurodegenerative disease that affects nearly 1 million people in the United States … Continue reading CIRM commits $60 million for Parkinson’s research, joins #Take6ForPD awareness campaign
Meet CIRM’s growing world class team
The California Institute for Regenerative Medicine (CIRM) continues to build its world class team to deliver the full potential of regenerative medicine to the people of California and around the world. CIRM is rebuilding and expanding its team to meet new challenges and advance the mission of the Agency. Rafael Aguirre-Sacasa and Koren Temple-Perry join the growing … Continue reading Meet CIRM’s growing world class team
CIRM welcomes two additions to its leadership team
Left to right: Rafael Aguirre-Sacasa, General Counsel and Koren Temple-Perry, Senior Director of Marketing Communications The California Institute for Regenerative Medicine (CIRM) continues to build its world class team to deliver the full potential of regenerative medicine to the people of California and around the world. CIRM is pleased to welcome two new members to its … Continue reading CIRM welcomes two additions to its leadership team
CIRM invests $2.7 million in research to develop stem cell-based tendon tissue for shoulder injuries
The California Institute for Regenerative Medicine (CIRM) has awarded a $2.7 million research grant to Scripps Health to investigate the use of stem cells to engineer rotator cuff tendons in the lab that can then be used to repair common shoulder injuries. The rotator cuff is a group of four muscles and their attached tendons, … Continue reading CIRM invests $2.7 million in research to develop stem cell-based tendon tissue for shoulder injuries
Apply Now! Discovery Stage Funding + Webinar on April 7
The California Institute for Regenerative Medicine (CIRM) is pleased to announce the opening of our next round of Quest Awards (DISC2) for discovery stage research. The purpose of the Quest Awards is to promote discovery of promising new stem cell-based and/or gene therapy technologies that could be translated to enable broad use and ultimately, improve patient care. The expected … Continue reading Apply Now! Discovery Stage Funding + Webinar on April 7
CIRM welcomes new Chair, bids farewell to Art Torres and Jonathan Thomas
Dr. Vito Imbasciani was sworn in as the new Chair of the Board of the California Institute for Regenerative Medicine (CIRM) at its March meeting. Imbasciani (pictured above at left) was elected to the six-year term at CIRM’s January Board meeting. He will replace outgoing chair Jonathan Thomas, who has served in the position since 2011. “My experience … Continue reading CIRM welcomes new Chair, bids farewell to Art Torres and Jonathan Thomas
Meshing a passion for medicine with stem cell research
Kevin Brown is an adventurer at heart. He was a pre-med student when he found a unique way to combine his passion for medicine in neuroscience with his natural inclination to explore and discover through scientific research. A 2022 graduate of the California Institute for Regenerative Medicine’s (CIRM) Bridges to Stem Cell Research and Therapy … Continue reading Meshing a passion for medicine with stem cell research
Why diversity in clinical trials is essential
The California Institute for Regenerative Medicine (CIRM) is proud to join fellow advocates of clinical trial diversity in applauding a new law that will allow the U.S. Food & Drug Administration (FDA) to require diverse representation in clinical trials. A clinical trial, as defined by the FDA, tests potential treatments in human volunteers to see … Continue reading Why diversity in clinical trials is essential
Join the movement to fight rare diseases
Tomorrow, February 28th, is Rare Disease Day. It’s a day to remind ourselves of the millions of people, and their families, struggling with these diseases. These conditions are also called orphan diseases because, in many cases, drug companies were not interested in adopting them to develop treatments. Here at the California Institute for Regenerative Medicine (CIRM), we … Continue reading Join the movement to fight rare diseases
Investing in stem cell and gene therapy treatments for HIV
A recent article in Nature shared the news about a 53-year-old man in Germany who was declared free of HIV after receiving virus-resistant cells. The man—referred to as the “Düsseldorf patient”—was diagnosed with acute myeloid leukemia and underwent a stem cell transplant in 2013 that replaced his bone marrow cells with HIV-resistant stem cells from … Continue reading Investing in stem cell and gene therapy treatments for HIV
The Stem Cellar 